A citation-based method for searching scientific literature

Volker M Lauschke, Magnus Ingelman-Sundberg. Eur J Pharm Sci 2019
Times Cited: 29



Y Zhou, M Ingelman-Sundberg, V M Lauschke. Clin Pharmacol Ther 2017
Times Cited: 299




List of shared articles



Times cited

Pharmacogenomics in treatment of depression and psychosis: an update.
Marin Jukic, Filip Milosavljević, Espen Molden, Magnus Ingelman-Sundberg. Trends Pharmacol Sci 2022
1

Frequencies of clinically important CYP2C19 and CYP2D6 alleles are graded across Europe.
Jelena Petrović, Vesna Pešić, Volker M Lauschke. Eur J Hum Genet 2020
43

Challenges and opportunities associated with rare-variant pharmacogenomics.
Yitian Zhou, Roman Tremmel, Elke Schaeffeler, Matthias Schwab, Volker M Lauschke. Trends Pharmacol Sci 2022
1

Pharmacogenomics of Antidepressant and Antipsychotic Treatment: How Far Have We Got and Where Are We Going?
Roos van Westrhenen, Katherine J Aitchison, Magnus Ingelman-Sundberg, Marin M Jukić. Front Psychiatry 2020
41



Copy number variation profiling in pharmacogenetics CYP-450 and GST genes in Colombian population.
Brian Ramírez, María José Niño-Orrego, Daniel Cárdenas, Kevin Enrique Ariza, Karol Quintero, Nora Constanza Contreras Bravo, Caroll Tamayo-Agudelo, María Alejandra González, Paul Laissue, Dora Janeth Fonseca Mendoza. BMC Med Genomics 2019
5

Pharmacogenomics in the era of next generation sequencing - from byte to bedside.
Laura E Russell, Yitian Zhou, Ahmed A Almousa, Jasleen K Sodhi, Chukwunonso K Nwabufo, Volker M Lauschke. Drug Metab Rev 2021
11


Application of long-read sequencing to elucidate complex pharmacogenomic regions: a proof of principle.
Maaike van der Lee, William J Rowell, Roberta Menafra, Henk-Jan Guchelaar, Jesse J Swen, Seyed Yahya Anvar. Pharmacogenomics J 2022
2